Episode Details

Back to Episodes
223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO

223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO

Published 4 years, 2 months ago
Description
Our colleague Helen Branswell joins to explain the Covid-19 booster debate, the Biden Administration’s monkeypox response, and the long career of the soon-to-step-down Anthony Fauci. We also discuss the latest news in the life sciences, including a milestone for gene therapy, the tentative return of an IPO market, and the venture capital league table.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us